Navigation Links
Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting

zing an extremely sensitive assay method.

Conclusions

It was concluded that a single, intravesical dose of EOquin was well tolerated, and was not systemically absorbed when administered to patients immediately following TUR-BT for noninvasive bladder cancer. Based on the results of this Phase 2b study as well as a previously conducted Phase 1 study, a larger, Phase 3 trial of EOquin in non-invasive bladder cancer is being initiated.

Abstract #5434 -- Synergistic Interaction between the Oral Platinum Analog Satraplatin and Erlotinib

In preclinical studies, satraplatin was active in a number of various tumor models and in cells resistant to cisplatin, carboplatin and oxaliplatin. Erlotinib (Tarceva(R)) is a potent inhibitor of the tyrosine kinase domain of the epidermal growth factor receptor (EGFR). Since upregulation of the Erk and p38 pathways, which are downstream of EGFR, may play a role in the resistance to platinum analogs, the evaluation of whether inhibition of this pathway by erlotinib would enhance the sensitivity of non-small cell lung (A549, SW1573), colon (Lovo, WiDr) and ovarian (A2780, 2008) cancer cell lines to satraplatin was examined.

Conclusion

Satraplatin is synergistic with erlotinib, which may be related to changes in signaling, especially the p-Erk pathway. A randomized Phase 2 trial is currently investigating the clinical benefit of satraplatin and erlotinib, administered in a sequential schedule, for elderly patients with advanced non- small cell lung cancer (NSCLC).

Abstract #3118 -- SPI (IRL) -1620 Increases the Efficacy of Radiation Treatment in Mice Bearing Lymphoma Cell Induced Tumors

SPI (IRL)-1620 is a selective ETB receptor agonist that has been demonstrated in preclinical studies to selectively enhance tumor blood flow and potentiate the efficacy of chemotherapeutics in various tumor models. Improved transient blood flow to the tumor is associated with a net increase in tumor ox
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:12/17/2014)... 2014 Revenue and earnings above the ... and development In the past 2013/14 fiscal year ... percent to EUR 4.287 billion (last year: EUR 4.190 billion) ... to EUR 360 million. "Overall, 2013/14 was a successful fiscal ... , President and CEO of Carl Zeiss AG. "Thanks to ...
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 2, 2011 The Center for Radiation Therapy of ... patients in the Los Angeles area, has been awarded ... the result of a recent review by the American ... Radiation Oncology (ASTRO). Radiation oncology (radiation ...
... Va., March 2, 2011 Insmed Incorporated (Nasdaq: ... the one-for-10 reverse stock split of Insmed,s Common Stock ... 2, 2011, after the State Corporation Commission of the ... of Incorporation to effect the reverse stock split.  The ...
Cached Medicine Technology:The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation 2The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation 3One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective 2
(Date:12/20/2014)... News) -- The holidays can be anything but joyous ... trees, scented candles and other allergy triggers. "The ... have been packed away in dank basements or dusty ... patients," Dr. Rachna Shah, an affiliate faculty member at ... Loyola news release. Shah, who is also an ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The Doctor’s Office ... for the better part of a decade. They’ve treated ... a better, faster healthcare alternative to the Paramus ... announce three new additions to their staff of top-notch board ... Jill Zeiger MD. These new doctors will work ...
(Date:12/20/2014)... New York, New York (PRWEB) December 20, 2014 ... ) continue to move forward in U.S. ... a new study which suggests that children treated ... prolactin, a hormone linked to breast development and ... Psychopharmacology, looked at 34 children and adolescents who ...
(Date:12/20/2014)... (PRWEB) December 20, 2014 The aftermath of ... quite a stir, not only in Hollywood, but worldwide. ... 18th , the ripples of that attack are starting a ... jobs at risk. But they are not the only ... could be in for some embarrassing times ahead, agents and ...
(Date:12/20/2014)... Developers of FCPX 3rd Party ... for Final Cut Pro X entitled TranSlice Volume 5 ... users to create hand drawn text animations without having ... of Pixel Film Studios. “TranSlice Volume 5 was professionally ... easy to use interface.” , TranSlice Volume 5 from ...
Breaking Medicine News(10 mins):Health News:Holiday Trimmings Can Trigger Allergies 2Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:Pixel Film Studios released a new transition entitled TranSlice Volume 5 exclusively for Final Cut Pro X 2
... (fight against inflammation) that are 10, 000 times more ... nimusulide and aspirin have been developed and patented by ... Medical Sciences (AIIMS), situated in New Delhi, India, have ... about 10,000 times better than the commonly used pain ...
... is threatening to cause a major upheaval to the ... spread, according to the Coordinating Minister// for People’s Welfare, ... expressed fears on the dwindling poultry industry and a ... to the pandemic. ,The consequences would be ...
... the magnets that are sold in the market does not ... problems//. Magnet that are advertised over the net and sold ... value. ,Magnets are sought after by the successful ... it is all bogus. The research was done by ...
... not aware about dugs and its effect till 1980. But ... is a lot of information available from varied sources// such ... ,The information that is available in these formats has to ... made accessible. This was done by Dr. David Wishart, faculty ...
... symposium on Stem cell Research and Therapy was conducted ... was organized by LifeCell//, a pioneer in stem cell ... Research Institute, one of the reputed medical institutions in ... hematologist, CMC, Vellore, headed the symposium. Following a small ...
... Woodruff (R) said he had filed a bill (HB 1096) that ... would endanger the life or health of the mother. ... a Class C felony, carrying a two- to eight-year prison sentence. ... a state must pass a law and then appeal it to ...
Cached Medicine News:Health News:Does Magnet Therapy Posses Healing Powers? 2Health News:Drug Database Goes On Air 2Health News:Stem Cell Research - Changing Wishes to Possibilities and Possibilities to Reality 2
... The TL-100 uses technology that takes ... by automatically detecting and reading them. It ... recording the results, mark lenses as you ... contact lenses. Easy to use, the TL-100 ...
... The Kowa RC-XV3 camera is ... The automatic exposure system, ... sensitivity, the 2.5~300ws watt indication ... handling are the basic features ...
FF 450plus fundus camera for 35mm photography. Upgradeable basic instrument for brilliant image quality....
The new TRC-NW6 non-mydriatic retinal camera is the ideal instrument for the growing market in telemedicine and diabetic screening....
Medicine Products: